MIT biological engineers have identified several promising vaccine targets that could finally provide better protection against tuberculosis, the world’s deadliest infectious disease that kills more than 1 million people every year. The only current vaccine for TB, called BCG, was developed over 100 years ago from a weakened cow bacterium
